{"created":"2023-06-19T11:23:24.842910+00:00","id":3940,"links":{},"metadata":{"_buckets":{"deposit":"4eaf650e-cb4b-4473-9512-27c0d1d8989e"},"_deposit":{"created_by":3,"id":"3940","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"3940"},"status":"published"},"_oai":{"id":"oai:asahikawa-med.repo.nii.ac.jp:00003940","sets":["7","7:27:28"]},"author_link":["11871"],"item_6_alternative_title_3":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"胆道癌に対する新規分子標的治療としてのVEGFR・EGFR阻害剤vandetanib(ZD6474)の検討","subitem_alternative_title_language":"ja"}]},"item_6_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographic_titles":[{"bibliographic_title":"学位論文内容の要旨及び審査結果の要旨"}]}]},"item_6_description_25":{"attribute_name":"リンクURL","attribute_value_mlt":[{"subitem_description":"http://www.ncbi.nlm.nih.gov/pubmed/19319137 | http://www.ncbi.nlm.nih.gov/pubmed/19319137","subitem_description_type":"Other"}]},"item_6_description_28":{"attribute_name":"識別番号 その他","attribute_value_mlt":[{"subitem_description":"British Journal of Cancer: 100(8)：1257–1266","subitem_description_type":"Other"}]},"item_6_description_37":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"text","subitem_description_type":"Other"}]},"item_6_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_6_relation_24":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1038/sj.bjc.6604988","subitem_relation_type_select":"DOI"}}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"吉川, 大太郎","creatorNameLang":"ja"},{"creatorName":"ヨシカワ, ダイタロウ","creatorNameLang":"ja-Kana"},{"creatorName":"Yoshikawa, Daitaro","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-07-06"}],"displaytype":"detail","filename":"4663.pdf","filesize":[{"value":"273.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"4663.pdf","url":"https://asahikawa-med.repo.nii.ac.jp/record/3940/files/4663.pdf"},"version_id":"16cbc09b-7cbc-4f0b-8237-b6ce7edcdd79"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"旭川医科大学：博士（医学）（乙第419号）","subitem_subject_scheme":"Other"},{"subitem_subject":"学位授与年月日：平成22年3月25日","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signaling, as a novel molecular targeted therapy against cholangiocarcinoma","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signaling, as a novel molecular targeted therapy against cholangiocarcinoma","subitem_title_language":"en"}]},"item_type_id":"6","owner":"3","path":["6","7","28"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2012-07-11"},"publish_date":"2012-07-11","publish_status":"0","recid":"3940","relation_version_is_last":true,"title":["Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signaling, as a novel molecular targeted therapy against cholangiocarcinoma"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-05-24T07:32:33.916504+00:00"}